Phase I Study of Milatuzumab for Graft Versus Host Disease

This study is currently recruiting participants.
Verified January 2014 by Immunomedics, Inc.
Sponsor:
Collaborator:
Ohio State University
Information provided by (Responsible Party):
Immunomedics, Inc.
ClinicalTrials.gov Identifier:
NCT01663766
First received: August 7, 2012
Last updated: January 22, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)